Long
Caplin Point Laboratories
Fundamentals-
1)A very attractive smallcap company in the space of Pharma.
2)Company is beating the sectoral growth rate, operating profit, sales etc YoY.
3)numbers like Operating profit, net sales are doubling YoY @>20%
4)Aggressive expansions..
Keynote-->Its a good stock that can be accumulated at every dip, would probably be a multibagger.
CMP-560(18th May'2017)
1st target-700(6 months)
Disclaimer : I am a private Investor/trader who is just expressing his views. These are just my opinions and i am not giving any kind of free or paid calls. I am using this platform to share my knowledge and learn from other's knowledge. I might be/might not be invested in my opinions.
NOTE-->I give preference to the traders/investors who encourage me by commenting and liking my ideas.
1)A very attractive smallcap company in the space of Pharma.
2)Company is beating the sectoral growth rate, operating profit, sales etc YoY.
3)numbers like Operating profit, net sales are doubling YoY @>20%
4)Aggressive expansions..
Keynote-->Its a good stock that can be accumulated at every dip, would probably be a multibagger.
CMP-560(18th May'2017)
1st target-700(6 months)
Disclaimer : I am a private Investor/trader who is just expressing his views. These are just my opinions and i am not giving any kind of free or paid calls. I am using this platform to share my knowledge and learn from other's knowledge. I might be/might not be invested in my opinions.
NOTE-->I give preference to the traders/investors who encourage me by commenting and liking my ideas.
Trade active
First target Reached-CMP-709 (6th July'2017)Keep holding for more gains, anticipating 1000 levels(6-7 months)
Trade active
Njoy money gains and keep holding more gains!target 1000(5-6 months)
CMP-747(13th July'2017)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.